Trial
NCT05815186
Ladarixin With Sotorasib in Advanced NSCLC - Phase II
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
—
Condition
Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Intervention
Sotorasib
Why stopped
Study record has been combined with NCT05815173 (Phase I/II study).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-29